XML 83 R50.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Entities and Acquisitions - Summary of Financial Information of Theravance Respiratory Company, LLC (Details) - USD ($)
$ in Thousands
 7 Months Ended 12 Months Ended
Jul. 20, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Variable Interest Entity [Line Items]        
Total revenue   $ 358,711 $ 310,463 $ 331,339
Other income, net   (2,997) (4,969) (3,373)
Income tax expense, net   13,996 14,376 66,687
Net income   23,392 179,722 220,262
Royalty revenue        
Variable Interest Entity [Line Items]        
Total revenue   $ 241,733 $ 238,846 $ 311,645
Theravance Respiratory Company, LLC        
Variable Interest Entity [Line Items]        
Operating expenses $ (332)      
Income from operations 71,697      
Other income, net 10      
Realized loss (39,386)      
Income tax expense, net 1      
Changes in fair values of equity and long-term investments, net (8,884)      
Net income 23,438      
Theravance Respiratory Company, LLC | Royalty revenue        
Variable Interest Entity [Line Items]        
Total revenue $ 72,029